Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content☆
To access this article, please choose from the options below
☆ This work was supported in part by the J. Coller Foundation.
PII: S0021-9150(07)00206-7
doi:10.1016/j.atherosclerosis.2007.03.043
© 2007 Elsevier Ireland Ltd. All rights reserved.
